aTyr Pharma's total assets for Q1 2025 were $97.25M, an increase of 0.43% from the previous quarter. ATYR total liabilities were $22.38M for the fiscal quarter, a -17.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.